- Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
- It is important to use Symbicort every day, even if you have no COPD symptoms at the time.
The usual dose is 2 inhalations twice a day. Symbicort is not recommended for children or adolescents under 18 years of age.
If you have been taking steroid tablets for your COPD, your doctor may reduce the number of tablets that you take, once you start to use Symbicort. If you have been taking oral steroid tablets for a long time, your doctor may want you to have blood tests from time to time. When reducing oral steroid tablets, you may feel generally unwell even though your chest symptoms may be improving. You might experience symptoms such as a stuffy or runny nose, weakness or joint or muscle pain and rash (eczema). If any of these symptoms bother you, or if symptoms such as headache, tiredness, nausea (feeling sick) or vomiting (being sick) occur, please contact your doctor immediately. You may need to take other medication if you develop allergic or arthritic symptoms. You should speak to your doctor if you are concerned as to whether you should continue to use Symbicort.
Your doctor may consider adding steroid tablets to your usual treatment during periods of stress (for example, when you have a chest infection or before an operation).
If you feel you are getting breathless or wheezy while using Symbicort, you should continue to use Symbicort but go to see your doctor as soon as possible, as you may need additional treatment.
Contact your doctor immediately if:
- Your breathing is getting worse or you often wake up at night feeling breathless.
- Your chest starts to feel tight in the morning or your chest tightness lasts longer than usual.
- These signs could mean that your COPD is not being properly controlled and you may need different or additional treatment immediately.
Your doctor may also prescribe other bronchodilator drugs, for example anticholinergics (such as tiotropium or ipratropium bromide) for your COPD disease.
- Before starting to use your Symbicort, remove it from the foil wrapper. Throw away the wrapper as well as the drying agent which is inside the wrapper. If the drying agent has leaked out of its packet, do not use the inhaler.
- After you have taken the inhaler out of its foil wrapper, you should use it within 3 months. Write the use by date (3 months from opening the wrapper) on the inhaler label to remind you when to stop using the inhaler.
- The parts of your inhaler are shown in the picture. The inhaler will already be assembled when you first receive it. Do not take it apart. If the canister becomes loose, put it back in the inhaler and keep using the inhaler.
You need to prepare your inhaler for use in the following situations:
- If you are using your new Symbicort for the first time.
- If you have not used it for more than 7 days.
- If it has been dropped.
To prepare your inhaler for use, follow the instructions below:
1. Shake the inhaler well for at least 5 seconds to mix the contents of the aerosol canister.
2. Remove the mouthpiece cover by pressing lightly on the bumps on the side. The strap on the mouthpiece cover will stay attached to the inhaler.
3. Hold the inhaler upright. Then press the counter (on the top of the inhaler) to release a puff into the air. You can use one or both hands, as shown in the pictures.
4. Release your finger(s) from the counter.
5. Wait for 10 seconds, shake well and then repeat steps 3 and 4.
6. Your inhaler is now ready for use.
Each time you need to take an inhalation, follow the instructions below:
1. Shake the inhaler well for at least 5 seconds to mix the contents of the aerosol canister.
2. Remove the mouthpiece cover by pressing lightly on the bumps on the side. Check that the mouthpiece is not blocked.
3. Hold your inhaler upright (using one or both hands). Breathe out gently.
4. Place the mouthpiece gently between your teeth. Close your lips.
5. Start to breathe in slowly and deeply through your mouth. Press the counter (on the top of the inhaler) firmly to release a puff. Keep breathing in for a short while after pressing the counter. Breathing in at the same time as pressing the counter ensures that the medicine reaches your lungs.
6. Hold your breath for 10 seconds, or for as long as it is comfortable.
7. Before you breathe out, release your finger from the counter and remove the inhaler from your mouth. Keep the inhaler upright.
8. Then breathe out slowly. To take another inhalation, shake the inhaler well for at least 5 seconds and repeat steps 3 to 7.
9. Replace the mouthpiece cover.
10. Rinse your mouth with water after your daily morning and evening doses and spit it out.
Your doctor, nurse or pharmacist may suggest that you use a spacer device (e.g. AeroChamber Plus Flow Vu or AeroChamber Plus). Follow the instructions in the leaflet that is packed with the spacer device.
- Wipe the inside and outside of the mouthpiece at least once a week with a dry tissue.
- Do not use water or liquids and do not remove the canister from the inhaler.
- The counter on the top of your inhaler tells you how many puffs (actuations) are left in your Symbicort. It starts with 120 puffs when it is full.
- Each time you take an inhalation, or release a puff into the air, the arrow counts down towards zero (‘0’).
- When the arrow first enters the yellow area, this means that there are about 20 puffs left.
- When the arrow reaches ‘0’, you must stop using your new Symbicort. Your inhaler may not feel empty and it may seem as though it still works. However, you will not get the right amount of medicine if you keep using it.
If you use more Symbicort than you should, contact your doctor or pharmacist for advice. The following effects may happen: trembling, headache or a rapid heartbeat.
- If you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose.
- Do not take a double dose to make up for a forgotten dose.
Before you stop using Symbicort, you should talk to your doctor or your pharmacist. If you stop using Symbicort the signs and symptoms of COPD may worsen.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
The active substances are budesonide and formoterol fumarate dihydrate. Each puff (actuation) contains 200 micrograms of budesonide and 6 micrograms of formoterol fumarate dihydrate.
The other ingredients are apaflurane (HFA 227), povidone and macrogol. This is a CFC-free inhaler.
This medicine contains fluorinated greenhouse gases. Each inhaler contains 10.6 g of apaflurane (HFC-227ea) corresponding to 0.034 tonne CO2 equivalent (global warming potential GWP= 3,220).
Symbicort is an inhaler containing your medicine. The pressurised canister, with attached dose indicator, contains a white suspension for inhalation. The canister is fitted into a red plastic actuator with a white plastic mouthpiece and an integrated grey plastic dust cap. Each inhaler contains 120 puffs (actuations) after it has been prepared for use. Each inhaler is individually packed in a foil wrapper containing a drying agent.
Symbicort, 200 micrograms/6 micrograms/actuation pressurised inhalation, suspension (Budesonide/Formoterol fumarate dihydrate) is available in packs of one inhaler.
The Marketing Authorisation for Symbicort is held by
AstraZeneca UK Limited
1 Francis Crick Avenue
Cambridge
CB2 0AA
UK
Symbicort is manufactured by
AstraZeneca Dunkerque Production (AZDP)
224 Avenue de la Dordogne
59640
Dunkerque
France
This medicinal product is authorised in the Member States of the EEA under the following names:
Country Trade name and strength
Austria Symbicort 160 Mikrogramm /4,5 Mikrogramm/Inhalation Druckgasinhalation, Suspension
Belgium Symbicort 160 microgram /4,5 microgram/inhalatie, aërosol, suspensie
Symbicort 160 microgrammes /4,5 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé
Symbicort 160 Mikrogramm /4,5 Mikrogramm/Inhalation, Druckgasinhalation, Suspension
Bulgaria Симбикорт 160 микрограма /4,5 микрограма/впръскване Суспензия под налягане за инхалация
Croatia Symbicort 160 mikrograma /4,5 mikrograma po potisku, stlačeni inhalat, suspenzija
Cyprus Symbicort 160 μικρογραμμάρια /4,5 μικρογραμμάρια/ψεκασμό
Czech Republic Symbicort 160 micrograms /4,5 micrograms/inhalation, suspension in pMDI
Denmark Symbicort 160 mikrogram /4.5 mikrogram/inhalation
Estonia Symbicort
Finland Symbicort 160 mikrog /4.5 mikrog/inhalaatio
France Symbicort 200/6 micro grammes par inhalation, suspension pour inhalation en flacon préssurisé
Germany Symbicort 160 Mikrogramm /4,5 Mikrogramm pro Inhalation Druckgasinhalation, Suspension
Greece Symbicort 160 μικρογραμμάρια /4,5 μικρογραμμάρια/ψεκασμό
Hungary Symbicort 4,5 mikrogramm /160 mikrogramm/ adag túlnyomásos inhalációs szuszpenzió
Iceland Symbicort 160 míkrógrömm /4,5 míkrógrömm/ inhalation
Ireland Symbicort 200 micrograms /6 micrograms/inhalation
Italy Symbicort
Latvia Symbicort 160 mikrogrami /4.5 mikrogrami/ inhalācijā, izsmidzinājumā, aerosols inhalācijām zem spiediena
Lithuania Symbicort 160 mikrogramų/4,5 mikrogramo/išpurškime suslėgtoji įkvepiamoji suspensija
Luxembourg Symbicort 160 microgrammes /4,5 microgrammes/inhalation, suspension pour inhalation en flacon pressurisé
Malta Symbicort 200 micrograms /6 micrograms/inhalation
Netherlands Symbicort aërosol 200/6, 200 microgram /6 microgram per dosis, aërosol, suspensie
Norway Symbicort 160 mikrogram /4.5 mikrogram/ inhalasjon
Poland Symbicort
Portugal Symbicort 160 microgramas /4,5 microgramas/inalação Suspensão pressurizada para inalação
Romania Symbicort 160 micrograme /4.5 micrograme/inhalaţie, suspensie de inhalat presurizată
Slovakia Symbicort 160 mikrogamov /4,5 mikrogamov/inhalačná dávka, inhalačná suspenzia v tlakovom obale
Slovenia Symbicort 160 mikrogramov /4,5 mikrograma na vdih, inhalacijska suspenzija pod tlakom
Spain Symbicort 160 microgramos /4,5 microgramos/inhalación suspensión para inhalación en envase a presión
Sweden Symbicort 160 mikrogram /4.5 mikrogram/inhalation
United Kingdom Symbicort 200 micrograms/6 micrograms per actuation pressurised inhalation, suspension
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name Symbicort 200/6
Reference number 17901/0293
This is a service provided by the Royal National Institute of Blind People.
Symbicort is a trademark of the AstraZeneca group of companies.